Compare $IART vs $TNDM | Chartloom

Compare

$IART vs $TNDM

Integra Lifesciences Holdings Corp · Tandem Diabetes Care Inc

IART

Integra Lifesciences Holdings Corp

TNDM

Tandem Diabetes Care Inc

Compare $IART vs $TNDM

Comparing Integra Lifesciences Holdings Corp and Tandem Diabetes Care Inc

IARTIntegra Lifesciences Holdings Corp

TNDMTandem Diabetes Care Inc

IARTIntegra Lifesciences Holdings Corp

Market cap

$1.05B

P/E (TTM)

—

Forward P/E (NTM)

4.99x

Forward P/S (NTM)

0.60x

Rev growth (TTM)

0.8%

YTD performance

11.9%

52W performance

-9.3%

FCF yield

-1.4%

TNDMTandem Diabetes Care Inc

Market cap

$1.10B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.95x

Rev growth (TTM)

4.0%

YTD performance

-25.2%

52W performance

5.0%

FCF yield

-9.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

IART

TNDM

Detailed metrics comparison

IART

Integra Lifesciences Holdings Corp

TNDM

Tandem Diabetes Care Inc

Market Cap

IART$1.05B

TNDM$1.10B

Enterprise Value

IART$1.05B

TNDM$1.65B

Price

IART$13.44

TNDM$16.11

P/E Ratio

IARTN/A

TNDMN/A

P/S Ratio

IART0.63x

TNDM1.06x

EV/Sales

IART0.63x

TNDM1.58x

EV/EBITDA

IART3.92x

TNDM241.82x

P/B Ratio

IART0.95x

TNDM8.80x

P/FCF Ratio

IARTN/A

TNDMN/A

EV/FCF

IART-73.87x

TNDM-15.26x

PEG Ratio

IARTN/A

TNDMN/A

Forward P/E (NTM)

IART4.99x

TNDMN/A

Forward P/S (NTM)

IART0.60x

TNDM0.95x

Revenue (TTM)

IART$1.66B

TNDM$1.04B

Revenue Growth (YoY)

IART0.8%

TNDM4.0%

Forward Rev Growth

IART3.2%

TNDM12.2%

Gross Margin (TTM)

IART43.1%

TNDM56.0%

Operating Margin (TTM)

IART4.0%

TNDM0.0%

EBITDA Margin (TTM)

IART16.1%

TNDM-2.4%

Net Margin (TTM)

IART-0.1%

TNDM-6.1%

FCF Margin (TTM)

IART-0.9%

TNDM-10.4%

Net Income (TTM)

IART$-2M

TNDM$-63M

FCF (TTM)

IART$-14M

TNDM$-108M

EPS (TTM)

IART$0.00

TNDM-$0.92

ROE (TTM)

IART-70.0%

TNDM-4597.0%

ROA (TTM)

IART-20.0%

TNDM-623.0%

ROIC (TTM)

IART-25.0%

TNDM-1058.0%

Cash

IART$0

TNDM$63M

Debt

IART$0

TNDM$607M

Net Cash/Debt

IART$0

TNDM$-545M

Current Ratio (TTM)

IART3.60x

TNDM3.18x

Quick Ratio (TTM)

IART1.80x

TNDM2.44x

Debt/Equity (TTM)

IART1.79x

TNDM4.66x

Debt/Assets (TTM)

IART0.0%

TNDM0.0%

Interest Coverage (TTM)

IARTN/A

TNDMN/A

Net Debt/EBITDA (TTM)

IART0.00x

TNDM0.00x

Beta

IART1.27

TNDM1.62

52W Performance

IART-9.3%

TNDM5.0%

YTD Performance

IART11.9%

TNDM-25.2%

% from 52W High

IART-34.4%

TNDM-45.7%

% from 52W Low

IART54.5%

TNDM31.4%

Asset Turnover (TTM)

IART0.46x

TNDM1.03x

FCF Yield (TTM)

IART-1.4%

TNDM-9.8%

Earnings Yield (TTM)

IART-0.2%

TNDM-5.7%

Dividend Yield (TTM)

IARTN/A

TNDMN/A

Rule of 40

IART-0.0

TNDM-6.4

EV/GP/RG

IART0.26

TNDM0.17

Ticker research

View IART research View TNDM research

Metric	IART Integra Lifesciences Holdings Corp	TNDM Tandem Diabetes Care Inc
Market & Valuation
Market Cap	$1.05B	$1.10B
Enterprise Value	$1.05B	$1.65B
Price	$13.44	$16.11
P/E Ratio	N/A	N/A
P/S Ratio	0.63x	1.06x
EV/Sales	0.63x	1.58x
EV/EBITDA	3.92x	241.82x
P/B Ratio	0.95x	8.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-73.87x	-15.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	4.99x	N/A
Forward P/S (NTM)	0.60x	0.95x
Revenue & Growth
Revenue (TTM)	$1.66B	$1.04B
Revenue Growth (YoY)	0.8%	4.0%
Forward Rev Growth	3.2%	12.2%
Profitability
Gross Margin (TTM)	43.1%	56.0%
Operating Margin (TTM)	4.0%	0.0%
EBITDA Margin (TTM)	16.1%	-2.4%
Net Margin (TTM)	-0.1%	-6.1%
FCF Margin (TTM)	-0.9%	-10.4%
Net Income (TTM)	$-2M	$-63M
FCF (TTM)	$-14M	$-108M
EPS (TTM)	$0.00	-$0.92
ROE (TTM)	-70.0%	-4597.0%
ROA (TTM)	-20.0%	-623.0%
ROIC (TTM)	-25.0%	-1058.0%
Financial Health
Cash	$0	$63M
Debt	$0	$607M
Net Cash/Debt	$0	$-545M
Current Ratio (TTM)	3.60x	3.18x
Quick Ratio (TTM)	1.80x	2.44x
Debt/Equity (TTM)	1.79x	4.66x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.27	1.62
52W Performance	-9.3%	5.0%
YTD Performance	11.9%	-25.2%
% from 52W High	-34.4%	-45.7%
% from 52W Low	54.5%	31.4%
Efficiency & Yields
Asset Turnover (TTM)	0.46x	1.03x
FCF Yield (TTM)	-1.4%	-9.8%
Earnings Yield (TTM)	-0.2%	-5.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.0	-6.4
EV/GP/RG	0.26	0.17
Ticker research	View IART research	View TNDM research

Valuation

P/S Ratio

IART

0.63x

TNDM

1.06x

EV/FCF

IART

-73.87x

TNDM

-15.26x

Growth & revenue

Revenue Growth TTM

TNDM

4.0%

IART

0.8%

Forward Revenue Growth

TNDM

12.2%

IART

3.2%

Profitability & performance

Gross Margin

TNDM

56.0%

IART

43.1%

ROE

IART

-70.0%

TNDM

-4597.0%

FCF Yield %

IART

-1.4%

TNDM

-9.8%

52-Week Performance

TNDM

5.0%

IART

-9.3%

Detailed metrics comparison

IART

Integra Lifesciences Holdings Corp

TNDM

Tandem Diabetes Care Inc

Market Cap

IART$1.05B

TNDM$1.10B

Enterprise Value

IART$1.05B

TNDM$1.65B

Price

IART$13.44

TNDM$16.11

P/E Ratio

IARTN/A

TNDMN/A

P/S Ratio

IART0.63x

TNDM1.06x

EV/Sales

IART0.63x

TNDM1.58x

EV/EBITDA

IART3.92x

TNDM241.82x

P/B Ratio

IART0.95x

TNDM8.80x

P/FCF Ratio

IARTN/A

TNDMN/A

EV/FCF

IART-73.87x

TNDM-15.26x

PEG Ratio

IARTN/A

TNDMN/A

Forward P/E (NTM)

IART4.99x

TNDMN/A

Forward P/S (NTM)

IART0.60x

TNDM0.95x

Revenue (TTM)

IART$1.66B

TNDM$1.04B

Revenue Growth (YoY)

IART0.8%

TNDM4.0%

Forward Rev Growth

IART3.2%

TNDM12.2%

Gross Margin (TTM)

IART43.1%

TNDM56.0%

Operating Margin (TTM)

IART4.0%

TNDM0.0%

EBITDA Margin (TTM)

IART16.1%

TNDM-2.4%

Net Margin (TTM)

IART-0.1%

TNDM-6.1%

FCF Margin (TTM)

IART-0.9%

TNDM-10.4%

Net Income (TTM)

IART$-2M

TNDM$-63M

FCF (TTM)

IART$-14M

TNDM$-108M

EPS (TTM)

IART$0.00

TNDM-$0.92

ROE (TTM)

IART-70.0%

TNDM-4597.0%

ROA (TTM)

IART-20.0%

TNDM-623.0%

ROIC (TTM)

IART-25.0%

TNDM-1058.0%

Cash

IART$0

TNDM$63M

Debt

IART$0

TNDM$607M

Net Cash/Debt

IART$0

TNDM$-545M

Current Ratio (TTM)

IART3.60x

TNDM3.18x

Quick Ratio (TTM)

IART1.80x

TNDM2.44x

Debt/Equity (TTM)

IART1.79x

TNDM4.66x

Debt/Assets (TTM)

IART0.0%

TNDM0.0%

Interest Coverage (TTM)

IARTN/A

TNDMN/A

Net Debt/EBITDA (TTM)

IART0.00x

TNDM0.00x

Beta

IART1.27

TNDM1.62

52W Performance

IART-9.3%

TNDM5.0%

YTD Performance

IART11.9%

TNDM-25.2%

% from 52W High

IART-34.4%

TNDM-45.7%

% from 52W Low

IART54.5%

TNDM31.4%

Asset Turnover (TTM)

IART0.46x

TNDM1.03x

FCF Yield (TTM)

IART-1.4%

TNDM-9.8%

Earnings Yield (TTM)

IART-0.2%

TNDM-5.7%

Dividend Yield (TTM)

IARTN/A

TNDMN/A

Rule of 40

IART-0.0

TNDM-6.4

EV/GP/RG

IART0.26

TNDM0.17

Ticker research

View IART research View TNDM research

Metric	IART Integra Lifesciences Holdings Corp	TNDM Tandem Diabetes Care Inc
Market & Valuation
Market Cap	$1.05B	$1.10B
Enterprise Value	$1.05B	$1.65B
Price	$13.44	$16.11
P/E Ratio	N/A	N/A
P/S Ratio	0.63x	1.06x
EV/Sales	0.63x	1.58x
EV/EBITDA	3.92x	241.82x
P/B Ratio	0.95x	8.80x
P/FCF Ratio	N/A	N/A
EV/FCF	-73.87x	-15.26x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	4.99x	N/A
Forward P/S (NTM)	0.60x	0.95x
Revenue & Growth
Revenue (TTM)	$1.66B	$1.04B
Revenue Growth (YoY)	0.8%	4.0%
Forward Rev Growth	3.2%	12.2%
Profitability
Gross Margin (TTM)	43.1%	56.0%
Operating Margin (TTM)	4.0%	0.0%
EBITDA Margin (TTM)	16.1%	-2.4%
Net Margin (TTM)	-0.1%	-6.1%
FCF Margin (TTM)	-0.9%	-10.4%
Net Income (TTM)	$-2M	$-63M
FCF (TTM)	$-14M	$-108M
EPS (TTM)	$0.00	-$0.92
ROE (TTM)	-70.0%	-4597.0%
ROA (TTM)	-20.0%	-623.0%
ROIC (TTM)	-25.0%	-1058.0%
Financial Health
Cash	$0	$63M
Debt	$0	$607M
Net Cash/Debt	$0	$-545M
Current Ratio (TTM)	3.60x	3.18x
Quick Ratio (TTM)	1.80x	2.44x
Debt/Equity (TTM)	1.79x	4.66x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.27	1.62
52W Performance	-9.3%	5.0%
YTD Performance	11.9%	-25.2%
% from 52W High	-34.4%	-45.7%
% from 52W Low	54.5%	31.4%
Efficiency & Yields
Asset Turnover (TTM)	0.46x	1.03x
FCF Yield (TTM)	-1.4%	-9.8%
Earnings Yield (TTM)	-0.2%	-5.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.0	-6.4
EV/GP/RG	0.26	0.17
Ticker research	View IART research	View TNDM research